TY - JOUR AU - Ishiyama, M. AU - Soine, L. A. AU - Vesselle, H. J. PY - 2017 DA - 2017// TI - Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis JO - EJNMMI Res VL - 7 UR - https://doi.org/10.1186/s13550-017-0315-y DO - 10.1186/s13550-017-0315-y ID - Ishiyama2017 ER - TY - JOUR AU - Mostard, R. L. AU - Van Kuijk, S. M. AU - Verschakelen, J. A. PY - 2012 DA - 2012// TI - A predictive tool for an effective use of F18-FDG PET in assessing activity of sarcoidosis JO - BMC Pulm Med VL - 12 UR - https://doi.org/10.1186/1471-2466-12-57 DO - 10.1186/1471-2466-12-57 ID - Mostard2012 ER - TY - JOUR AU - Mostard, R. L. AU - Voo, S. AU - van Kroonenburgh, M. J. PY - 2011 DA - 2011// TI - Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis JO - Respir Med VL - 105 UR - https://doi.org/10.1016/j.rmed.2011.08.012 DO - 10.1016/j.rmed.2011.08.012 ID - Mostard2011 ER - TY - JOUR AU - Ohira, H. AU - Tsujino, I. AU - Yoshinaga, K. PY - 2011 DA - 2011// TI - (1)(8)F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis JO - Eur J Nucl Med Mol Imaging VL - 38 UR - https://doi.org/10.1007/s00259-011-1832-y DO - 10.1007/s00259-011-1832-y ID - Ohira2011 ER - TY - JOUR AU - Blankstein, R. AU - Osborne, M. AU - Naya, M. PY - 2014 DA - 2014// TI - Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis JO - J Am Coll Cardiol VL - 63 UR - https://doi.org/10.1016/j.jacc.2013.09.022 DO - 10.1016/j.jacc.2013.09.022 ID - Blankstein2014 ER - TY - JOUR AU - Manabe, O. AU - Ohira, H. AU - Yoshinaga, K. AU - Naya, M. AU - Oyama-Manabe, N. AU - Tamaki, N. PY - 2017 DA - 2017// TI - Qualitative and quantitative assessments of cardiac sarcoidosis using 18F-FDG PET JO - Ann Nucl Cardiol VL - 3 UR - https://doi.org/10.17996/anc.17-00015 DO - 10.17996/anc.17-00015 ID - Manabe2017 ER - TY - JOUR AU - Wahl, R. L. AU - Jacene, H. AU - Kasamon, Y. AU - Lodge, M. A. PY - 2009 DA - 2009// TI - From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors JO - J Nucl Med VL - 50 UR - https://doi.org/10.2967/jnumed.108.057307 DO - 10.2967/jnumed.108.057307 ID - Wahl2009 ER - TY - JOUR AU - Ahmadian, A. AU - Brogan, A. AU - Berman, J. PY - 2014 DA - 2014// TI - Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis JO - J Nucl Cardiol VL - 21 UR - https://doi.org/10.1007/s12350-014-9901-9 DO - 10.1007/s12350-014-9901-9 ID - Ahmadian2014 ER - TY - JOUR AU - Hirata, K. AU - Kobayashi, K. AU - Wong, K. P. PY - 2014 DA - 2014// TI - A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0105682 DO - 10.1371/journal.pone.0105682 ID - Hirata2014 ER - TY - JOUR AU - Blomberg, B. A. AU - Bashyam, A. AU - Ramachandran, A. PY - 2015 DA - 2015// TI - Quantifying [(1)(8)F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-3074-x DO - 10.1007/s00259-015-3074-x ID - Blomberg2015 ER - TY - JOUR AU - Manabe, O. AU - Yoshinaga, K. AU - Ohira, H. PY - 2016 DA - 2016// TI - The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis JO - J Nucl Cardiol VL - 23 UR - https://doi.org/10.1007/s12350-015-0226-0 DO - 10.1007/s12350-015-0226-0 ID - Manabe2016 ER - TY - JOUR AU - Ishida, Y. AU - Yoshinaga, K. AU - Miyagawa, M. PY - 2014 DA - 2014// TI - Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations JO - Ann Nucl Med VL - 28 UR - https://doi.org/10.1007/s12149-014-0806-0 DO - 10.1007/s12149-014-0806-0 ID - Ishida2014 ER - TY - STD TI - Manabe O, Kroenke M, Aikawa T, et al. Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake. J Nucl Cardiol. 2017. https://doi.org/10.1007/s12350-017-1122-6. ID - ref13 ER - TY - JOUR AU - Gormsen, L. C. AU - Christensen, N. L. AU - Bendstrup, E. AU - Tolbod, L. P. AU - Nielsen, S. S. PY - 2013 DA - 2013// TI - Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis JO - J Nucl Cardiol VL - 20 UR - https://doi.org/10.1007/s12350-013-9798-8 DO - 10.1007/s12350-013-9798-8 ID - Gormsen2013 ER - TY - JOUR AU - Siddiqui, A. AU - Madhu, S. V. AU - Sharma, S. B. AU - Desai, N. G. PY - 2015 DA - 2015// TI - Endocrine stress responses and risk of type 2 diabetes mellitus JO - Stress VL - 18 UR - https://doi.org/10.3109/10253890.2015.1067677 DO - 10.3109/10253890.2015.1067677 ID - Siddiqui2015 ER - TY - JOUR AU - Burke, S. J. AU - Batdorf, H. M. AU - Eder, A. E. PY - 2017 DA - 2017// TI - Oral corticosterone administration reduces insulitis but promotes insulin resistance and hyperglycemia in male nonobese diabetic mice JO - Am J Pathol VL - 187 UR - https://doi.org/10.1016/j.ajpath.2016.11.009 DO - 10.1016/j.ajpath.2016.11.009 ID - Burke2017 ER - TY - JOUR AU - Hwang, J. L. AU - Weiss, R. E. PY - 2014 DA - 2014// TI - Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment JO - Diabetes Metab Res Rev VL - 30 UR - https://doi.org/10.1002/dmrr.2486 DO - 10.1002/dmrr.2486 ID - Hwang2014 ER - TY - JOUR AU - Cadoudal, T. AU - Leroyer, S. AU - Reis, A. F. PY - 2005 DA - 2005// TI - Proposed involvement of adipocyte glyceroneogenesis and phosphoenolpyruvate carboxykinase in the metabolic syndrome JO - Biochimie VL - 87 UR - https://doi.org/10.1016/j.biochi.2004.12.005 DO - 10.1016/j.biochi.2004.12.005 ID - Cadoudal2005 ER - TY - JOUR AU - Taybi, T. AU - Nimmo, H. G. AU - Borland, A. M. PY - 2004 DA - 2004// TI - Expression of phosphoenolpyruvate carboxylase and phosphoenolpyruvate carboxylase kinase genes. Implications for genotypic capacity and phenotypic plasticity in the expression of crassulacean acid metabolism JO - Plant Physiol VL - 135 UR - https://doi.org/10.1104/pp.103.036962 DO - 10.1104/pp.103.036962 ID - Taybi2004 ER - TY - JOUR AU - Bural, G. G. AU - Torigian, D. A. AU - Burke, A. PY - 2010 DA - 2010// TI - Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept JO - Mol Imaging Biol VL - 12 UR - https://doi.org/10.1007/s11307-009-0258-4 DO - 10.1007/s11307-009-0258-4 ID - Bural2010 ER - TY - JOUR AU - Borra, R. AU - Lautamaki, R. AU - Parkkola, R. PY - 2008 DA - 2008// TI - Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus JO - Metabolism VL - 57 UR - https://doi.org/10.1016/j.metabol.2008.05.015 DO - 10.1016/j.metabol.2008.05.015 ID - Borra2008 ER - TY - JOUR AU - Jang, J. K. AU - Jang, H. J. AU - Kim, J. S. AU - Kim, T. K. PY - 2017 DA - 2017// TI - Focal fat deposition in the liver: diagnostic challenges on imaging JO - Abdom Radiol (NY) VL - 42 UR - https://doi.org/10.1007/s00261-017-1049-z DO - 10.1007/s00261-017-1049-z ID - Jang2017 ER - TY - JOUR AU - Yoshikawa, J. AU - Matsui, O. AU - Takashima, T. PY - 1987 DA - 1987// TI - Focal fatty change of the liver adjacent to the falciform ligament: CT and sonographic findings in five surgically confirmed cases JO - AJR Am J Roentgenol VL - 149 UR - https://doi.org/10.2214/ajr.149.3.491 DO - 10.2214/ajr.149.3.491 ID - Yoshikawa1987 ER - TY - JOUR AU - Cadoudal, T. AU - Blouin, J. M. AU - Collinet, M. PY - 2007 DA - 2007// TI - Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes JO - Diabetologia VL - 50 UR - https://doi.org/10.1007/s00125-006-0560-5 DO - 10.1007/s00125-006-0560-5 ID - Cadoudal2007 ER - TY - JOUR AU - Iozzo, P. AU - Geisler, F. AU - Oikonen, V. PY - 2003 DA - 2003// TI - Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET study JO - J Nucl Med VL - 44 ID - Iozzo2003 ER - TY - STD TI - Keramida G, Hunter J, Peters AM. Hepatic glucose utilisation in hepatic steatosis and obesity. Biosci Rep. 2016;36(6). ID - ref26 ER - TY - JOUR AU - Kanda, H. AU - Tateya, S. AU - Tamori, Y. PY - 2006 DA - 2006// TI - MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity JO - J Clin Invest VL - 116 UR - https://doi.org/10.1172/JCI26498 DO - 10.1172/JCI26498 ID - Kanda2006 ER - TY - JOUR AU - Burke, A. AU - Lucey, M. R. PY - 2004 DA - 2004// TI - Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation JO - Am J Transplant VL - 4 UR - https://doi.org/10.1111/j.1600-6143.2004.00432.x DO - 10.1111/j.1600-6143.2004.00432.x ID - Burke2004 ER - TY - JOUR AU - Harrison, S. A. AU - Oliver, D. AU - Arnold, H. L. AU - Gogia, S. AU - Neuschwander-Tetri, B. A. PY - 2008 DA - 2008// TI - Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease JO - Gut VL - 57 UR - https://doi.org/10.1136/gut.2007.146019 DO - 10.1136/gut.2007.146019 ID - Harrison2008 ER - TY - JOUR AU - McPherson, S. AU - Stewart, S. F. AU - Henderson, E. AU - Burt, A. D. AU - Day, C. P. PY - 2010 DA - 2010// TI - Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease JO - Gut VL - 59 UR - https://doi.org/10.1136/gut.2010.216077 DO - 10.1136/gut.2010.216077 ID - McPherson2010 ER - TY - JOUR AU - Ahmed, A. M. AU - Ebid, M. E. AU - Ajlan, A. M. AU - Al-Mallah, M. H. PY - 2017 DA - 2017// TI - Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease JO - Abdom Radiol (NY) VL - 42 UR - https://doi.org/10.1007/s00261-017-1166-8 DO - 10.1007/s00261-017-1166-8 ID - Ahmed2017 ER -